ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,840.00
      -0.03%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      85.70
      -0.93%
      Bitcoin
      57,152.34
      2.34%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      07/08/20242:00AMGlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNYSE:ADCTADC Therapeutics SA
      07/08/20242:00AMBusiness WireSignum Surgical Granted FDA De Novo Clearance for BioHealx™
      07/08/20242:00AMBusiness WireEpsilogen announces CTA approval for Phase Ib trial of MOv18 IgE in platinum-resistant ovarian cancer
      07/08/20242:00AMGlobeNewswire Inc.Renforcement en Europe
      07/08/20242:00AMGlobeNewswire Inc.Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical DevelopmentNASDAQ:CGCarlyle Group Inc
      07/08/20242:00AMGlobeNewswire Inc.Volta Finance Limited - Dividend DeclarationLSE:VTAVolta Finance Limited
      07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsLSE:31QWAegon Nv
      07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsLSE:AGNAegon Nv
      07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsTG:AENDRegistered Shares
      07/08/20242:00AMGlobeNewswire Inc.Evolution de la Gouvernance de la sociétéEU:OREGEOrege
      07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsBIT:AGNAegon N V
      07/08/20242:00AMGlobeNewswire Inc.EUR 200 million share buyback program beginsXE:AENDAegon N V
      07/08/20242:00AMGlobeNewswire Inc.LEXIBOOK: 2023-24 ANNUAL RESULTS IN LINE WITH EXPECTATIONS: ANNUAL SALES AT €58.6M (+14.4%). EBIT AND NET RESULT UP RESPECTIVELY TO +6.0M€ AND +5.0M€ THANKS TO AN EXCEPTIONAL CONJUNCTION OF POSITIVE FACTORS.EU:ALLEXLexibook Linguistic Electronic System SA
      07/08/20242:00AMBusiness WireSpineGuard : Réalisation de l’augmentation de capital avec maintien du droit préférentiel de souscription pour un montant brut de 1,13 M€EU:ALSGDSpineguard
      07/08/20242:00AMGlobeNewswire Inc.Strengthened presence in Europe
      07/08/20242:00AMGlobeNewswire Inc.OKX to List XRADERS' XR Token on its Spot Market, Expanding Trading Options
      07/08/20242:00AMGlobeNewswire Inc.Transaction in Own SharesTG:PANPaypoint PLC
      07/08/20242:00AMGlobeNewswire Inc.Evolution de la Gouvernance de la sociétéLSE:0QSUOrege Sa
      07/08/20242:00AMGlobeNewswire Inc.Volta Finance Limited - Dividend DeclarationLSE:VTASVolta Finance Limited
      07/08/20242:00AMGlobeNewswire Inc.Volta Finance Limited - Dividend DeclarationEU:VTAVolta Finance Limited
      07/08/20242:00AMGlobeNewswire Inc.Subsea7 share repurchasesTG:SOCSubsea 7 SA
      07/08/20242:00AMPR Newswire (US)National Plants at Work Week 2024: Embrace Vitamin Plant for a Balanced Life
      07/08/20242:00AMPR Newswire (US)Biotrend and Freepoint Eco-Systems Join Forces in Strategic Partnership to Create Value from Waste Plastics
      07/08/20242:00AMPR Newswire (US)Biotrend and Freepoint Eco-Systems Join Forces in Strategic Partnership to Create Value from Waste Plastics
      07/08/20241:56AMGlobeNewswire Inc.AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19LSE:0Q77Ab Science Sa
      07/08/20241:56AMGlobeNewswire Inc.AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19EU:ABAb Science
      07/08/20241:56AMGlobeNewswire Inc.AB Science announces positive results of its Phase 2 study evaluating masitinib in Covid-19TG:A8DAb Science
      07/08/20241:56AMGlobeNewswire Inc.AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19EU:ABAb Science
      07/08/20241:56AMGlobeNewswire Inc.AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19LSE:0Q77Ab Science Sa
      07/08/20241:56AMGlobeNewswire Inc.AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19TG:A8DAb Science